Chief Financial Officer.
A former Director of Finance for the worldwide anti-infective and psychiatric drug development division of GlaxoSmithKline plc and Divisional Finance Manager at Whittington Syndicate Management Limited, Scot qualified as a Chartered Accountant with Coopers & Lybrand in 1994.
Prior to moving into accountancy, Scot graduated with a BSc (Hons) in Molecular Biology and spent three years conducting original research in molecular genetics with the UK's largest charity, Cancer Research UK.
In addition to his other professional qualifications, Scot has been an Associate Member of the Chartered Institute of Arbitrators since 1997.